{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:59:47Z","timestamp":1790848787701,"version":"4.1.0"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Ferroptosis is an iron-dependent form of regulated cell death driven by membrane lipid peroxidation and has become an important therapeutic vulnerability in cancer. The Hippo pathway, through its transcriptional effectors Yes-associated protein and transcriptional coactivator with PDZ-binding motif, links cell contact, mechanical stress, metabolism and tissue organization to cancer-cell state. Recent studies show that Hippo activity can either sensitize or protect tumor cells from ferroptosis, depending on the tissue microenvironment, effector-driven signaling and treatment pressure. This review integrates the molecular mechanisms of Hippo signaling and ferroptosis, then summarizes the evidence across four mechanistic layers: cell-contact and mechanotransduction inputs, direct control of ferroptosis machinery, metabolic and redox integration, and epigenetic or non-coding regulation. We further examine how this axis shapes cancer progression, stem-like states, drug resistance, tumor\u2013stroma communication and immune therapy. Therapeutic strategies include direct disruption of YAP\/TAZ\u2013TEAD activity, pharmacological induction of ferroptosis, metabolic co-targeting, natural-product combinations, oncolytic viruses, engineered extracellular vesicles and nanomedicine. The major translational need is to define when Hippo activation marks ferroptosis vulnerability and when it marks ferroptosis resistance. Patient stratification, spatially resolved models, dynamic pharmacodynamic biomarkers and clinically realistic combination studies will be essential for translating these microenvironment-specific signaling cascades into a precision treatment strategy.<\/jats:p>","DOI":"10.3389\/fmed.2026.1982771","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:42:30Z","timestamp":1790847750000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hippo pathway in cancer ferroptosis: from mechanism insights to targeted therapies"],"prefix":"10.3389","volume":"13","author":[{"given":"Ziyi","family":"Xu","sequence":"first","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruochen","family":"Yang","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hudabia","family":"Akram","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Gu","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer. Nature reviews","volume":"22","author":"Lei","year":"2022","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","article-title":"Exploiting ferroptosis vulnerabilities in cancer","volume":"26","author":"Nakamura","year":"2024","journal-title":"Nat Cell Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/s43018-025-01037-7","article-title":"Prospects for ferroptosis therapies in cancer","author":"Ubellacker","year":"2025","journal-title":"Nature Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1089\/ars.2022.0048","article-title":"Ferroptosis as ultimate target of cancer therapy","volume":"39","author":"Motooka","year":"2023","journal-title":"Antioxidants Redox Signaling"},{"key":"B8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","article-title":"Ferroptosis in cancer and cancer immunotherapy","volume":"42","author":"Zhao","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.tcb.2022.11.003","article-title":"Targeting ferroptosis to treat colorectal cancer","volume":"33","author":"Yan","year":"2023","journal-title":"Trends Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.2147\/jhc.S500084","article-title":"Roles and mechanisms of ferroptosis in sorafenib resistance for hepatocellular carcinoma","volume":"11","author":"Liu","year":"2024","journal-title":"J Hepatocell Carcinoma"},{"key":"B13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","article-title":"Targeting the hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nature reviews","volume":"19","author":"Dey","year":"2020","journal-title":"Drug Discovery"},{"key":"B14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s43018-022-00473-z","article-title":"YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches","volume":"4","author":"Piccolo","year":"2023","journal-title":"Nature Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41568-023-00579-1","article-title":"Insights into recent findings and clinical application of YAP and TAZ in cancer. Nature reviews","volume":"23","author":"Franklin","year":"2023","journal-title":"Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1107505","DOI":"10.3389\/fonc.2022.1107505","article-title":"The role of hippo pathway in ferroptosis","volume":"12","author":"Xiang","year":"2022","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu","year":"2015","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","article-title":"The hippo pathway: biology and pathophysiology","volume":"88","author":"Ma","year":"2019","journal-title":"Ann Rev Biochem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","article-title":"The biology of YAP\/TAZ: hippo signaling and beyond","volume":"94","author":"Piccolo","year":"2014","journal-title":"Physiol Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","article-title":"YAP\/TAZ upstream signals and downstream responses","volume":"20","author":"Totaro","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","article-title":"Interplay between YAP\/TAZ and metabolism","volume":"28","author":"Koo","year":"2018","journal-title":"Cell Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nrm.2017.87","article-title":"Mechanobiology of YAP and TAZ in physiology and disease. Nature reviews","volume":"18","author":"Panciera","year":"2017","journal-title":"Mol Cell Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.devcel.2019.06.003","article-title":"The hippo signaling pathway in development and disease","volume":"50","author":"Zheng","year":"2019","journal-title":"Dev Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-pathol-030420-105050","article-title":"The hippo pathway in liver homeostasis and pathophysiology","volume":"16","author":"Driskill","year":"2021","journal-title":"Ann Rev Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/cs20201474","article-title":"The hippo pathway in cancer: yAP\/TAZ and TEAD as therapeutic targets in cancer","volume":"136","author":"Cunningham","year":"2022","journal-title":"Clin Sci (London)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/0109298665333926240927074528","article-title":"Ferroptosis as a therapeutic target in neurodegenerative diseases: exploring the mechanisms and potential of treating Alzheimer's Disease and Parkinson's Disease","volume":"31","author":"Zhong","year":"2024","journal-title":"Protein Pept Lett"},{"key":"B28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","article-title":"Role of mitochondria in ferroptosis","volume":"73","author":"Gao","year":"2019","journal-title":"Mol Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","article-title":"The chemical basis of ferroptosis","volume":"15","author":"Conrad","year":"2019","journal-title":"Nat Chem Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and transferrin regulate ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Mol Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis. Nature reviews","volume":"25","author":"Dixon","year":"2024","journal-title":"Mol Cell Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1699375","DOI":"10.1080\/23723556.2019.1699375","article-title":"Hippo pathway effectors YAP\/TAZ as novel determinants of ferroptosis","volume":"7","author":"Yang","year":"2020","journal-title":"Mol Cell Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.tcb.2022.05.005","article-title":"Roles of YAP\/TAZ in ferroptosis","volume":"32","author":"Magesh","year":"2022","journal-title":"Trends Cell Biology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.gendis.2020.05.004","article-title":"Regulation of ferroptosis in cancer cells by YAP\/TAZ and hippo pathways: the therapeutic implications","volume":"8","author":"Sun","year":"2021","journal-title":"Genes Diseases"},{"key":"B42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40364-022-00365-5","article-title":"The biology of YAP in programmed cell death","volume":"10","author":"Cheng","year":"2022","journal-title":"Biomark Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7150\/ijbs.83586","article-title":"Role of YAP signaling in regulation of programmed cell death and drug resistance in cancer","volume":"20","author":"Zhou","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"104349","DOI":"10.1016\/j.critrevonc.2024.104349","article-title":"The crosstalk between oncogenic signaling and ferroptosis in cancer","volume":"197","author":"Pang","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41392-020-00216-5","article-title":"The interaction between ferroptosis and lipid metabolism in cancer","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"217697","DOI":"10.1016\/j.canlet.2025.217697","article-title":"Glutathione metabolism in ferroptosis and cancer therapy","volume":"621","author":"Xue","year":"2025","journal-title":"Cancer Lett"},{"key":"B47","doi-asserted-by":"publisher","first-page":"103095","DOI":"10.1016\/j.critrevonc.2020.103095","article-title":"Ferroptosis: an emerging approach for targeting cancer stem cells and drug resistance","volume":"155","author":"Elgendy","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/cells12141820","article-title":"Ferroptosis in cancer progression","volume":"12","author":"Zhang","year":"2023","journal-title":"Cells"},{"key":"B49","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.3390\/cancers15245728","article-title":"Unleashing the power of yes-associated protein in ferroptosis and drug resistance in breast cancer, with a special focus on therapeutic strategies","volume":"15","author":"Malla","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"101967","DOI":"10.1016\/j.gendis.2025.101967","article-title":"Ferroptosis and prostate cancer: a translational path from molecular mechanisms to precision therapy","volume":"13","author":"Huang","year":"2026","journal-title":"Genes Diseases"},{"key":"B51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","article-title":"Ferroptosis and the tumor microenvironment","volume":"43","author":"Cui","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.trecan.2019.02.010","article-title":"YAP\/TAZ signaling and resistance to cancer therapy","volume":"5","author":"Nguyen","year":"2019","journal-title":"Trends Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","article-title":"Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling","volume":"572","author":"Wu","year":"2019","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","article-title":"The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma","volume":"28","author":"Yang","year":"2019","journal-title":"Cell Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1158\/1541-7786.Mcr-19-0691","article-title":"A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer","volume":"18","author":"Yang","year":"2020","journal-title":"Mol Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1038\/s41388-021-01676-x","article-title":"DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the hippo pathway","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1093\/neuonc\/noab114","article-title":"MEF2C silencing downregulates NF2 and E-cadherin and enhances erastin-induced ferroptosis in meningioma","volume":"23","author":"Bao","year":"2021","journal-title":"Neuro Oncol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41388-023-02599-5","article-title":"E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer","volume":"42","author":"Minikes","year":"2023","journal-title":"Oncogene"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1111\/odi.14925","article-title":"Manganese drives ferroptosis of cancer cells via YAP\/TAZ phase separation activated ACSL4 in OSCC","volume":"30","author":"Chen","year":"2024","journal-title":"Oral Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"107202","DOI":"10.1016\/j.jbc.2024.107202","article-title":"YAP\/TAZ-mediated regulation of laminin 332 is enabled by \u03b24 integrin repression of ZEB1 to promote ferroptosis resistance","volume":"300","author":"Goel","year":"2024","journal-title":"J Biol Chem"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1158\/1541-7786.Mcr-20-0534","article-title":"The hippo pathway effector YAP promotes ferroptosis via the E3 ligase SKP2","volume":"19","author":"Yang","year":"2021","journal-title":"Mol Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41420-021-00468-2","article-title":"O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP\/TFRC pathway in liver cancer","volume":"7","author":"Zhu","year":"2021","journal-title":"Cell Death Discov"},{"key":"B63","doi-asserted-by":"publisher","first-page":"751593","DOI":"10.3389\/fcell.2021.751593","article-title":"Oncogenic activation of YAP signaling sensitizes ferroptosis of hepatocellular carcinoma via ALOXE3-mediated lipid peroxidation accumulation","volume":"9","author":"Qin","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"104618","DOI":"10.1016\/j.isci.2022.104618","article-title":"SUFU suppresses ferroptosis sensitivity in breast cancer cells via hippo\/YAP pathway","volume":"25","author":"Fang","year":"2022","journal-title":"iScience"},{"key":"B65","doi-asserted-by":"publisher","first-page":"7560569","DOI":"10.1155\/2022\/7560569","article-title":"MITD1 deficiency suppresses clear cell renal cell carcinoma growth and migration by inducing ferroptosis through the TAZ\/SLC7A11 pathway","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B66","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3892\/ol.2023.13676","article-title":"HIF-1\u03b1 inhibits ferroptosis and promotes malignant progression in non-small cell lung cancer by activating the hippo-YAP signalling pathway","volume":"25","author":"Zheng","year":"2023","journal-title":"Oncol Lett"},{"key":"B67","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/kjm2.12889","article-title":"CMTM5 influences hippo\/YAP axis to promote ferroptosis in glioma through regulating WWP2-mediated LATS2 ubiquitination","volume":"40","author":"Fan","year":"2024","journal-title":"Kaohsiung J Med Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-024-06464-5","article-title":"CYLD regulates cell ferroptosis through hippo\/YAP signaling in prostate cancer progression","volume":"15","author":"Gu","year":"2024","journal-title":"Cell Death Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e2415814","DOI":"10.1002\/advs.202415814","article-title":"MISP suppresses ferroptosis via MST1\/2 kinases to facilitate YAP activation in non-small cell lung cancer","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41420-025-02506-9","article-title":"TAZ\/NRF2 positive feedback loop contributes to proliferation in bladder cancer through antagonistic ferroptosis","volume":"11","author":"Song","year":"2025","journal-title":"Cell Death Discov"},{"key":"B71","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41392-023-01555-9","article-title":"CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties","volume":"8","author":"Lv","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1007\/s11010-023-04847-4","article-title":"YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH","volume":"479","author":"Fu","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"B73","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.freeradbiomed.2025.03.019","article-title":"YAP-mediated DDX3X confers resistance to ferroptosis in breast cancer cells by reducing lipid peroxidation","volume":"232","author":"Dai","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.freeradbiomed.2025.12.020","article-title":"SLC38A5 drives colorectal cancer ferroptosis resistance through the hippo-YAP\/Nrf2 axis","volume":"244","author":"Zhang","year":"2026","journal-title":"Free Radic Biol Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41419-026-08746-6","article-title":"Aberrant activation of epigenetic BRD9-DGAT1 axis promotes lipid droplets deposition and ferroptosis resistance in YAP-high prostate cancer","volume":"17","author":"Zhu","year":"2026","journal-title":"Cell Death Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"153969","DOI":"10.1016\/j.bbrc.2026.153969","article-title":"YAP induces ferroptosis vulnerability in breast cancer via GCH1 suppression","volume":"823","author":"Chunthaboon","year":"2026","journal-title":"Biochem Biophys Res Commun"},{"key":"B77","doi-asserted-by":"publisher","first-page":"150037","DOI":"10.1016\/j.bbrc.2024.150037","article-title":"Overexpression of transcription factor TBX5 inhibits the activation of YAP1-TEAD1 pathway to promote ferroptosis in lung cancer cells","volume":"718","author":"Ma","year":"2024","journal-title":"Biochem Biophys Res Communications"},{"key":"B78","doi-asserted-by":"publisher","first-page":"110064","DOI":"10.1016\/j.abb.2024.110064","article-title":"IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells","volume":"758","author":"Li","year":"2024","journal-title":"Archives Bioch Biophys"},{"key":"B79","doi-asserted-by":"publisher","first-page":"110832","DOI":"10.1016\/j.isci.2024.110832","article-title":"CircPOLA2 sensitizes non-small cell lung cancer cells to ferroptosis and suppresses tumorigenesis via the merlin-YAP signaling pathway","volume":"27","author":"Xu","year":"2024","journal-title":"iScience"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/ijms27021020","article-title":"MED12 dictates epithelial ovarian cancer cell ferroptosis sensitivity via YAP-TEAD1 signaling","volume":"27","author":"Luo","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e22756","DOI":"10.1002\/advs.202522756","article-title":"KMT2C loss promotes NF2-wildtype meningioma progression and ferroptosis sensitivity via epigenetic repression of hippo signaling","volume":"13","author":"Zhang","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1158\/1535-7163.Mct-24-0145","article-title":"YAP1 suppression by ZDHHC7 is associated with ferroptosis resistance and poor prognosis in ovarian clear cell carcinoma","volume":"23","author":"Furutake","year":"2024","journal-title":"Mol Cancer Ther"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e14351","DOI":"10.15252\/emmm.202114351","article-title":"YAP\/TAZ and ATF4 drive resistance to sorafenib in hepatocellular carcinoma by preventing ferroptosis","volume":"13","author":"Gao","year":"2021","journal-title":"EMBO Mol Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"4750671","DOI":"10.1155\/2022\/4750671","article-title":"Epithelial membrane protein 1 promotes sensitivity to RSL3-induced ferroptosis and intensifies gefitinib resistance in head and neck cancer","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B85","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s10735-026-10802-6","article-title":"PDK4 acts via hippo signaling to inhibit ferroptosis and reduce gemcitabine sensitivity in pancreatic cancer","volume":"57","author":"Jin","year":"2026","journal-title":"J Mol Histol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"19422","DOI":"10.1038\/s41598-026-50108-x","article-title":"Cancer-associated fibroblasts -derived tenascin-C activates the hippo\/TAZ pathway to suppress ferroptosis and confer cisplatin resistance in esophageal cancer","volume":"16","author":"Xiao","year":"2026","journal-title":"Sci Rep"},{"key":"B87","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41419-024-06485-0","article-title":"AURKA inhibition induces Ewing's Sarcoma apoptosis and ferroptosis through NPM1\/YAP1 axis","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e0189723","DOI":"10.1128\/jvi.01897-23","article-title":"Oncolytic Newcastle disease virus induced degradation of YAP through E3 ubiquitin ligase PRKN to exacerbate ferroptosis in tumor cells","volume":"98","author":"Sun","year":"2024","journal-title":"J Virol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"156804","DOI":"10.1016\/j.phymed.2025.156804","article-title":"The cardiac glycoside periplocymarin sensitizes gastric cancer to ferroptosis via the ATP1A1-src-YAP\/TAZ-TFRC axis","volume":"142","author":"Ke","year":"2025","journal-title":"Phytomedicine"},{"key":"B90","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3892\/mmr.2025.13734","article-title":"Schisantherin A induces ferroptosis in non-small cell lung cancer through activation of the YAP\/ACSL4\/TfR signaling pathway","volume":"33","author":"Zhu","year":"2026","journal-title":"Mol Med Rep"},{"key":"B91","doi-asserted-by":"publisher","first-page":"19865","DOI":"10.1038\/s41598-026-49614-9","article-title":"Ginkgetin enhances the antitumor effect of taxol on human breast cancer MCF-7 cells via ferroptosis mediated by the MDM2-p53-YAP1 axis","volume":"16","author":"Li","year":"2026","journal-title":"Sci Rep"},{"key":"B92","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1142\/S0192415X23500271","article-title":"Targeting ferroptosis in cancer by natural products: an updated review","volume":"51","author":"Guo","year":"2023","journal-title":"Am J Chin Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"156304","DOI":"10.1016\/j.metabol.2025.156304","article-title":"Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response","volume":"170","author":"Pan","year":"2025","journal-title":"Metab Clin Exp"},{"key":"B94","doi-asserted-by":"publisher","first-page":"8377","DOI":"10.7150\/thno.115860","article-title":"Engineered nanovesicle platform simultaneously triggers YAP-dependent ferroptosis and reprograms T-cell immunity through miR-150-3p codelivery in melanoma microenvironment","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"B95","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1039\/d5nr05059f","article-title":"Copper-verteporfin coordination nanoparticles to reverse ferroptosis resistance in pancreatic cancer therapy","volume":"18","author":"Jiang","year":"2026","journal-title":"Nanoscale"},{"key":"B96","doi-asserted-by":"publisher","first-page":"9257","DOI":"10.1038\/s41598-025-34454-w","article-title":"LBPs NPs suppress breast cancer progression by inhibiting YAP1 expression to induce ferroptosis and alter energy metabolism","volume":"16","author":"Zhao","year":"2026","journal-title":"Sci Rep"},{"key":"B97","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2025.04.029","article-title":"Exosomal SLC1A5 from senescent endothelial cells promotes gastric cancer progression by dampening ferroptosis via the EGFR\/SRC\/YAP1\/GPX4 signaling","volume":"235","author":"Zhang","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1038\/s44319-025-00515-4","article-title":"Hippo pathway controls biopterin metabolism to shield adjacent cells from ferroptosis in lung cancer","volume":"26","author":"Li","year":"2025","journal-title":"EMBO Rep"},{"key":"B99","doi-asserted-by":"publisher","first-page":"110725","DOI":"10.1016\/j.jbc.2025.110725","article-title":"USP52 inhibits cell ferroptosis via hippo-YAP pathway and blocks immunotherapy in colorectal cancer","volume":"301","author":"Zhou","year":"2025","journal-title":"J Biol Chem"},{"key":"B100","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/cas.70299","article-title":"Hippo pathway drives durable non-cell-autonomous ferroptosis resistance in lung cancer","volume":"117","author":"Saleh","year":"2026","journal-title":"Cancer Sci"},{"key":"B101","doi-asserted-by":"publisher","first-page":"a041919","DOI":"10.1101\/cshperspect.a041919","article-title":"Safety lessons for YAP\/TAZ-TEAD inhibition: from mechanism to translation","author":"Paul","year":"2026","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"813","DOI":"10.14670\/hh-18-838","article-title":"Ferroptosis: a key regulator and potential target for tissue injury","volume":"40","author":"Liu","year":"2025","journal-title":"Histol Histopathol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12272-021-01322-w","article-title":"The essential role of TAZ in normal tissue homeostasis","volume":"44","author":"Jeong","year":"2021","journal-title":"Arch Pharm Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ptr.8088","article-title":"Ferroptosis: potential opportunities for natural products in cancer therapy","volume":"38","author":"Nie","year":"2024","journal-title":"Phytother Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"110259","DOI":"10.1016\/j.jnutbio.2026.110259","article-title":"Natural products as modulators of ferroptosis: therapeutic implications and molecular mechanisms in disease treatment","volume":"151","author":"Tong","year":"2026","journal-title":"J Nutr Biochem"},{"key":"B106","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/mc.23527","article-title":"AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP\/SLC7A11 signaling pathway","volume":"62","author":"Chen","year":"2023","journal-title":"Mol Carcinog"},{"key":"B107","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3892\/ol.2024.14576","article-title":"Interference with ENO2 promotes ferroptosis and inhibits glycolysis in clear cell renal cell carcinoma by regulating hippo-YAP1 signaling","volume":"28","author":"Li","year":"2024","journal-title":"Oncol Lett"},{"key":"B108","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s10495-026-02349-4","article-title":"ZDHHC14-driven RUNX2 S-palmitoylation attenuates ferroptosis and enhances chemoresistance in ovarian cancer via the YAP1\/GLS1 axis","volume":"31","author":"Li","year":"2026","journal-title":"Apoptosis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1982771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:42:32Z","timestamp":1790847752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1982771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":108,"alternative-id":["10.3389\/fmed.2026.1982771"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1982771","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1982771"}}